Business

Result of General Meeting

Result of General Meeting.

articleScancell Holdings PlcAugust 1, 20133/company/scancell-hldgs-plc/news/result-of-general-meeting-23
Result of General Meeting

About this update from Scancell Holdings Plc

[{"type":"text","content":"\n \nRNS Number : 7297K Scancell Holdings Plc 01 August 2013  \n \n\n \nScancell Holdings plc\n(\"Scancell\" or the \"Company\")\nResult of General Meeting\n \nThe Board of Scancell announces that all resolutions put to shareholders at the Company's General Meeting held earlier today were duly passed.\n \nApplication has been made for a total of 28,888,888 new ordinary shares to be admitted to trading on AIM.  Dealing is expected to commence in respect of 22,222,222 new ordinary shares at 08:00 on 2 August 2013 and in respect of 6,666,666 new ordinary shares at 08:00 on 5 August 2013.\n \nIn conformity with rule 5.6.1 of Disclosure and Transparency Rules, the Board of the Company notifies the market of the following:\n \nThe total number of ordinary shares of 0.1p each in Scancell in issue following the admission of the 28,888,888 new ordinary shares will be 223,358,373 with each share carrying the right to one vote. There are no shares held in Treasury. The total number of voting rights in the Company will following admission of the Offer Shares therefore be 223,358,373. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Scancell under the FSA's Disclosure and Transparency Rules.\nDavid Evans, Non-Executive Chairman of Scancell, said:  \"With funding now secured, we can focus on advancing both of Scancell's cancer immunotherapy platforms to key value inflection points that we believe will further support their future role in the rapidly growing new approach to cancer treatment.   We look forward to providing updates on our progress in due course.\"\n \nFor more information, please visit www.scancell.co.uk or contact:\n \n\n\n\n\nFor Further Information: \nScancell Holdings Plc \nDavid Evans, Non Executive Chairman\nDr Richard Goodfellow, Joint CEO \n \n\n\n \n \n\n\n \n \n+44 (0) 7740084452\n+ 44 (0) 74 2323 0 497 \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFTI Consulting:\nSimon Conway/Mo Noonan \n\n\n\n\n\n+ 44 (0) 20 7831 3113 \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCenkos Securities plc:\n\n\n\n\n\n+44 (0) 20 7397 8900\n\n\n\n\nCamilla Hume/Stephen Keys\n\n\n\n\n\n\n\n\n\n\n\...

More updates from Scancell Holdings Plc